<?xml version="1.0" encoding="UTF-8"?>
<p>To simulate the mitochondrial dysfunction in PD, many studies used the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). This drug mimics PD-like symptoms and inhibits complex I of the respiratory chain [
 <xref rid="B142" ref-type="bibr">142</xref>â€“
 <xref rid="B144" ref-type="bibr">144</xref>] by decreasing ATP production and triggering the release of free radicals, thus leading to the death of dopaminergic neurons [
 <xref rid="B29" ref-type="bibr">29</xref>]. The mitochondrial dysfunction caused by PD may accelerate the progression of insulin resistance via increased production of ROS [
 <xref rid="B145" ref-type="bibr">145</xref>]. Therefore, it is possible that the mitochondrial dysfunction observed in PD could promote the development of T2DM.
</p>
